Document Detail


The role of oxidized regenerate cellulose to prevent cosmetic defects in oncoplastic breast surgery.
MedLine Citation:
PMID:  22953647     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Breast conserving surgery (BCS) combined with postoperative radiotherapy has become the gold standard of locoregional treatment for the majority of patients with early-stage breast cancer, offering equivalent survival and improved body image and lifestyle scores as compared to mastectomy. In an attempt to optimize the oncologic safety and cosmetic results of BCS, oncoplastic procedures (OPP) have been introduced in recent years combining the best principles of surgical oncology with those of plastic surgery. However, even with the use of OPP, cosmetic outcomes may result unsatisfying when a large volume of parenchyma has to be removed, particularly in small-medium size breasts.
AIM: The aim of this article is to report our preliminary results with the use of oxidized regenerate cellulose (ORC) (Tabotamp fibrillar, Johnson & Johnson; Ethicon, USA) as an agent to prevent cosmetic defects in patients undergoing OPP for breast cancer and to analyze the technical refinements that can enhance its efficacy in optimizing cosmetic defects.
METHODS: Different OPP are selected based on the location and size of the tumor as well as volume and shape of the breast. After excision of the tumor, glandular flaps are created by dissection of the residual parenchyma from the pectoralis and serratus muscles and from the skin. After careful haemostasis, five layers of ORC are positioned on the pectoralis major in the residual cavity and covered by advancement of the glandular flaps. Two additional layers of ORC are positioned above the flaps and covered by cutaneous-subcutaenous flaps.
RESULTS: The use of ORC after OPP has shown promising preliminary results, indicating a good tolerability and positive effects on cosmesis.
CONCLUSIONS: This simple and reliable surgical technique may allow not only to reduce the rate of post-operative bleeding and infection at the surgical site but also to improve cosmetic results.
Authors:
G Franceschini; G Visconti; D Terribile; C Fabbri; S Magno; A Di Leone; M Salgarello; R Masetti
Related Documents :
24604117 - Mir-506 suppresses proliferation and induces senescence by directly targeting the cdk4/...
23666187 - Bronze baby syndrome.
24518697 - Encapsulated papillary carcinoma of the breast: an overview.
23903407 - Prostate-specific kallikrein-related peptidases and their relation to prostate cancer b...
12481677 - Tumor-induced hypercalcemia: predictors of early mortality.
24150787 - Expression and prognostic role of skip in human breast carcinoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  16     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-09-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  966-71     Citation Subset:  IM    
Affiliation:
Multidisciplinary Breast Center, School of Medicine,Catholic University of the "Sacred Heart", Rome, Italy. franceschinigianluca@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary brea...
Next Document:  Traumatic forequarter amputation associated acute lung injury (ALI): report of one case.